Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in sterile injectable pharmaceutical manufacturing. Editor's ...
New York, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs ...
The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.
Within the past few years, key players have left the sterile manufacturing business. Can new technology and investment revitalize this critical market? The past five years have been troubled ones for ...
PARSIPPANY, N.J., Oct. 27, 2025 /PRNewswire/ -- Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is making progress ...
Injectable drug delivery is the mode of introduction of a drug directly into the bloodstream of a patient. Drugs are directly injected into the bloodstream of patients, owing to which they need to be ...
WuXi STA , a global contract research development and manufacturing organization (CRDMO), has launched a first high potency (HP), fully automated sterile injectable manufacturing line at its drug ...
BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the“Company”), an American biopharmaceutical ...
Undergraduate students recently visited the SMU to aseptically manufacture lipid nanoparticles. Credit: Nathaniel Milton. WEST LAFAYETTE, Ind. — A mobile laboratory that Eli Lilly and Company used to ...
Pfizer has increased its position in the $7 billion-plus market for sterile injectable drugs with a $360 million agreement to buy New Jersey-based InnoPharma. The US pharma giant wants a bigger slice ...
The global Generic Sterile Injectable Ecosystem Market is valued at USD 326.78 Billion in 2024 and is projected to reach a value of USD 1060.5 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...
Jubilant Pharmova subsidiary and contract manufacturer Jubilant HollisterStier LLC (JHS) has launched a $132 million new sterile fill and finish line at its Spokane manufacturing facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback